Export

EN
FR
Carboplatin
Essential medicine status
General description
Carboplatin is a platinum-based antineoplastic agent used to treat many types of cancer.
INN
Carboplatin
ATC codes
L01XA02
Medicine type
Chemical agent
EML status history
Changed in 2009 (TRS 958) for Retinoblastoma
Wikipedia
Carboplatin
DrugBank
Carboplatin
Recommendations
Section
Cytotoxic medicines
  • Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL
  • Parenteral > General injections > IV: 600 mg per 60 mL; 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL
  • Parenteral > General injections > IV: 600 mg per 60 mL; 450 mg per 45 mL; 50 mg per 5 mL; 150 mg per 15 mL
  • Parenteral > General injections > IV: 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL; 50 mg per 5 mL
  • Parenteral > General injections > IV: 150 mg per 15 mL; 50 mg per 5 mL; 450 mg per 45 mL; 600 mg per 60 mL
Indications
Other specified carcinomas of ovary Retinoblastoma Osteosarcoma of bone or articular cartilage of unspecified sites Malignant neoplasms of breast Malignant neoplasms of nasopharynx Other specified malignant neoplasms of bronchus or lung Malignant neoplasms of cervix uteri Other specified gliomas of brain Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx Malignant neoplasms of kidney, except renal pelvis Other specified malignant neoplasms of the ovary Germ cell tumour of testis Malignant neoplasms of nasopharynx Malignant neoplasms of hypopharynx Malignant neoplasms of oropharynx